Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT00901160
Eligibility Criteria:
Inclusion Criteria:
* patients on aspirin and/or clopidogrel for at least 10 days, having non-ambulatory, non-cardiac, elective surgery
Exclusion Criteria:
* anemia (Hb \< 100) or thrombocytopenia (platelet count \< 80), having any known clotting abnormalities
* family history of clotting abnormalities
* concurrently on NSAIDs, warfarin therapy or other treatments affecting platelet function
* renal impairment (Cr \> 110 mg for females or Cr \> 125 mg) or INR \> 1.2
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT00901160
Study Brief:
Protocol Section:
NCT00901160